NONOF:OTCMKTS
Novo Nordisk A/S
US$ 37.12
arrow_downward
-0.70%(-0.26) Siku 1
2 Okt, 12:32:07 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NONOF...
Fungua
US$ 37.95
Juu
US$ 38.44
Chini
US$ 36.83
Mtaji wa soko
127.77B
Wastani wa kiasi cha mauzo
elfu 134.38
Kiasi cha mauzo ya hisa
elfu 10.49
Juu kwa wiki 52
US$ 64.75
Chini kwa wiki 52
US$ 34.00
Beta
0.63
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Fungua
US$ 37.95
Juu
US$ 38.44
Chini
US$ 36.83
Mtaji wa soko
127.77B
Wastani wa kiasi cha mauzo
elfu 134.38
Kiasi cha mauzo ya hisa
elfu 10.49
Juu kwa wiki 52
US$ 64.75
Chini kwa wiki 52
US$ 34.00
Beta
0.63
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
dakika 27 zilizopita
Novo Nordisk stock after-hours at EUR 33.14: minus 0.48 percent versus prior close
TipRanks
·
dakika 43 zilizopita
Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline
The Motley Fool
·
saa 1 iliyopita
Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Simply Wall Street
·
saa 13 zilizopita
Novo Nordisk (NVO) Stock Looks Reasonable Given Uncertain Long Term Earnings
Wasifu
Novo is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark's domestic economy, and it became the highest valued company in Europe. Wikipedia
Kuhusu Novo Nordisk A/S
Afisa Mkuu Mtendaji (CEO)Maziar Mike Doustdar
Wafanyakazielfu 66.7
Lilianzishwa21 Des 1923
Makao makuuBagsværd, Capital Region of Denmark, Denmaki
Sekta-
Tovutinovonordisk.com